Appointment booking for Dr. Noah Levit, MD, PHD is currently not available.Dr. Noah Levit, MD, PHD has not yet fully activated their profile on SelectWow.
Dr. Noah Levit, MD, PHD (he/him) is a Dermatologist in Hamden, CT with over 9 years of experience. What is your opinion of Dr. Noah Levit, MD, PHD? Rate this provider below so other people can make informed decision.
Gender
Male (Approximately 50% of Dermatologists in Hamden, CT are Male)
Education
State University of New York at Stony Brook, School of Medicine, 2016
Degree Type
MD (Approximately 83% of Dermatologists in Hamden, CT have MD degree)
Medical Specialties
Dermatologist (There are 6 Dermatologists available in Hamden, CT, which is about the same as the average number of Dermatologists in similar U.S. locations)
Experience
9+ Years of Experience (About 49% less years of experience compared to the average Dermatologist in Hamden, CT)
Languages Spoken
English
Research Publications
Approximately 50% of Dermatologists in Hamden, CT have available research publications
Dupilumab treatment restores lesional and nonlesional skin barrier function in adults and adolescents with atopic dermatitis irrespective of the filaggrin genotype: Results from an open-label, healthy-control-matched, phase 4 clinical study (BALISTAD).
Development of novel patient-reported outcome instruments to assess atopic dermatitis-associated dyspigmentation and xerosis in patients with skin of colour.
Pathophysiology of Prurigo Nodularis: Neuroimmune Dysregulation and the Role of Type 2 Inflammation.
Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin.
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Dupilumab Safety and Efficacy in a Phase III Open-Label Extension Trial in Children 6-11 Years of Age with Severe Atopic Dermatitis.
Dupilumab Treatment Leads to Rapid and Consistent Improvement of Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 5 Years.
Dupilumab Treatment is Not Associated with Increased Risk of Overall Skin Infections [Letter].
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials.
Do you have any questions about plastic surgery, dermatology and cosmetic dentistry treatments? You can now post those questions in SelectWow Forum and have our experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of questions, all for FREE! Register today and join the conversation!
Get Directions
Call: (203) 288-1142
